Vasamed, Inc.
VSMD · OTC
9/30/2006 | 6/30/2006 | 3/31/2006 | 12/31/2005 | |
|---|---|---|---|---|
| Revenue | $513 | $463 | $457 | $572 |
| % Growth | 10.7% | 1.5% | -20.2% | – |
| Cost of Goods Sold | $357 | $411 | $401 | $469 |
| Gross Profit | $156 | $52 | $56 | $103 |
| % Margin | 30.4% | 11.3% | 12.2% | 18.1% |
| R&D Expenses | $440 | $455 | $412 | $436 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $951 | $835 | $829 | $536 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,391 | $1,290 | $1,241 | $1,073 |
| Operating Income | $1,235 | $1,237 | $1,186 | $969 |
| % Margin | 240.7% | 267% | 259.6% | 169.4% |
| Other Income/Exp. Net | -$1,235 | -$1,237 | -$1,186 | -$969 |
| Pre-Tax Income | $1,234 | $1,237 | $1,183 | $809 |
| Tax Expense | $481 | $443 | $50 | $6 |
| Net Income | -$1,716 | -$1,680 | -$1,236 | -$976 |
| % Margin | -334.5% | -362.5% | -270.7% | -170.6% |
| EPS | -0.45 | -0.44 | -0.32 | -0.26 |
| % Growth | -2.3% | -37.5% | -23.1% | – |
| EPS Diluted | -0.45 | -0.44 | -0.32 | -0.26 |
| Weighted Avg Shares Out | 3,855 | 3,834 | 3,809 | 3,809 |
| Weighted Avg Shares Out Dil | 3,855 | 3,834 | 3,809 | 3,809 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $440 | $417 | $57 | $43 |
| EBITDA | -$795 | -$820 | -$1,129 | -$926 |
| % Margin | -155% | -177% | -247.2% | -161.9% |